Search
Castle Biosciences Inc
CSTLAdd to Watchlist
34.335USD
-0.545-1.56%
Market hours 09/24, 14:27（ET）
1.04BMarket Cap
LossP/E TTM
Castle Biosciences Inc (CSTL) Stock Price Target & Forecast
Analyst Rating
Based on 9 analysts giving stock ratings to Castle Biosciences Inc in the past month.
Strong Buy
5 Strong Buy
4 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
45.111USD+29.44%
CSTL Analyst Recommendation Trends
In the current month, CSTL has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CSTL average Analyst price target in the last month is 45.111.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
5
5
5
5
5
5
5
4
4
4
4
3
3
3
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9
9
9
8
8
8
8
7
CSTL Analyst Rating for Peer Comparison
Updated: Sep 23, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Dexcom Inc
DXCM
13
13
4
0
0
30
Stryker Corp
SYK
11
13
6
0
0
30
Medtronic PLC
MDT
9
10
11
0
0
30
Abbott Laboratories
ABT
11
12
6
0
0
29
Zimmer Biomet Holdings Inc
ZBH
2
6
21
0
0
29
Medline Ord Shs Class A
MDLN
10
12
6
0
0
28
Guardant Health Inc
GH
12
13
2
0
0
27
Insulet Corp
PODD
7
8
12
0
0
27
Repligen Corp
RGEN
5
14
3
0
0
22
Tandem Diabetes Care Inc
TNDM
4
8
10
0
0
22
Financial Forecasting
Based on analysts' estimates, CSTL EPS is projected to reach -0.371 in FY2026Q3, following reported EPS of -0.068 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.29
-0.49
-0.41
-0.37
-0.38
Actual
-0.08
-0.49
-0.07
--
--
Surprise
+72.23%
+0.84%
+83.34%
--
--
FAQs
What is Castle Biosciences Inc's expected revenue for the next quarter?
Castle Biosciences Inc's expected revenue is 92.00M.
What is Castle Biosciences Inc's price target?
Analysts forecast that Castle Biosciences Inc's price target is USD 45.11, with the highest forecast at USD 57.00 and the lowest forecast at USD 35.00.
How have Castle Biosciences IncCSTL's recent earnings per share performed?
The market expectation was USD -0.07, while Castle Biosciences IncCSTL's earnings per share (EPS) for the previous quarter was USD -0.49. EPS for the next quarter is expected at USD -0.37.
What is the analyst rating for Castle Biosciences Inc?
Based on the ratings of Castle Biosciences Inc's stock from 9 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.